v3.26.3
RESEARCH, DEVELOPMENT, AND CLINICAL TRIAL EXPENSES, NET (Details Narrative) - USD ($)
12 Months Ended
Aug. 25, 2025
Jul. 31, 2026
Jul. 31, 2025
Grant received from NCI   $ 936,363
Additional grants receivable   $ 1,118,288  
National Cancer Institute [Member]      
Grant received from NCI $ 2,000,000.0